क्यूआर कोड

35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience

Abstract Frontline high-dose therapy (HDT) is, in 2025, the standard of care for patients with multiple myeloma (MM) who are eligible for autologous stem cell transplantation (ASCT). Prior to high-dose melphalan, induction therapy with quadruplet combinations is also proposed systematically when pos...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Philippe Moreau, Cyrille Hulin, Alexis Talbot, Hélène Demarquette, Léo Caillot, Thomas Chalopin, Arthur Bobin, Salomon Manier, Xavier Leleu, Lionel Karlin, Denis Caillot, Cécile Sonntag, Pierre Feugier, Murielle Roussel, Romain Gounot, Margaret Macro, Mohamad Mohty, Laurent Garderet, Mourab Tiab, Frédérique Orsini-Piocelle, Laure Vincent, Nathalie Meuleman, Jean Fontan, Lidia Montes, Marie-Christiane Vekemans, Martine Escoffre-Barbe, Jean-Richard Eveillard, Jean-Marc Schiano de Colella, Jérôme Lambert, Jean-Yves Mary, Jean-Paul Fermand, Bertrand Arnulf, Jill Corre, Hervé Avet-Loiseau, Thierry Facon, Jean-Luc Harousseau, Cyrille Touzeau, Aurore Perrot
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Publishing Group 2025-10-01
श्रृंखला:Blood Cancer Journal
ऑनलाइन पहुंच:https://doi.org/10.1038/s41408-025-01387-6
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन